Abstract
Developing intrinsically mitochondria-targetable nanosystems for subcellular structure-oriented precise cancer therapy is highly desirable. Here, we conjugate the cluster determinant 44 (CD44)-targetable hyaluronic acid (HA) with cholesterol-poly(ethylene glycol)2k-NH2 and mitochondria-acting IR825-NH2 (a cyanine dye) to construct a self-assembled nanostructure (abbreviated as HA-IR825-Chol) for photothermal therapy. The HA-IR825-Chol exhibits improved photostability and desirable photothermal properties, and can rapidly and substantially enter CD44-over-expressed cancer cells and selectively accumulate in the mitochondria of the cells. Upon near-infrared laser irradiation, it can induce severe mitochondrial damage, which causes cytochrome c release and triggers cell apoptosis. Furthermore, we demonstrate the feasibility of loading the chemother-apeutics 10-hydroxycamptothecin (HCPT) into the hydrophobic cores of HA-IR825-Chol NPs for combined chemo-photothermal therapy. HCPT encapsulated within HA-IR825-Chol achieves significantly increased cellular uptake and simultaneous mitochondrial and nuclear localization, leading to the release of cytochrome c from mitochondria and upregulation of cleaved caspase-3, both of which contribute to the cell apop-tosis/death. In vivo experiments reveal the excellent tumor-targeting ability of HA-IR825-Chol/HCPT, ensuring the efficient tumor eradication by the chemo-photothermal therapy. This work exemplifies the development of an intrinsically mitochon-dria-targetable nanocarrier for precise subcellular structure-localized drug delivery, and the Choi-mediated rapid and massive endocytosis of the nanoagents may represent a robust strategy for enhancing the efficacies of nanomedicines.
摘要
摘要开发本身即具有线粒体靶向能力的亚细胞精准纳米诊疗试剂对于改善癌症治疗效果具有重要意义. 本文使用可靶向癌细胞表面过度表达的CD44抗原的透明质酸、 胆固醇-聚乙二醇-氨基和可作用于线粒体的花菁类染料IR825-NH2, 构建了一种可实现光热治疗的自组装纳米材料(HA-IR825-Chol). 相较于游离的IR825-NH2, 该结构具有更好的光稳定性、 更高的光热转换效率和对癌细胞的识别能力. HA-IR825-Chol可以有效靶向细胞线粒体, 并可以在近红外激光照射下诱导线粒体损伤. 此外, 我们通过疏水作用包裹了化疗试剂10-羟基喜树碱(HCPT)(所形成的药物命名为HAIR825-Chol/HCPT). 相关实验结果显示, 包裹于纳米材料后HCPT被细胞摄取的效率显著提高, 并能够同时分布于线粒体和细胞核中, 从而诱导线粒体中细胞色素c的释放和细胞中cleaved caspase-3的上调, 最终促进细胞凋亡与死亡. 另外, HA-IR825-Chol/HCPT优异的体内肿瘤靶向能力为光化疗联合治疗消除肿瘤提供了必要保证. 该工作实现了定位于线粒体的精准亚细胞药物递送, 并发展了利用胆固醇提高药物摄取速率和效率的策略, 预期将为提高纳米药物抗癌效果提供借鉴.
Similar content being viewed by others
References
Ott M, Gogvadze V, Orrenius S, et al. Mitochondria, oxidative stress and cell death. Apoptosis, 2007, 12: 913–922
Weinberg SE, Chandel NS. Targeting mitochondria metabolism for cancer therapy. Nat Chem Biol, 2015, 11: 9–15
Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov, 2010, 9: 447–464
Kwon HJ, Cha MY, Kim D, et al. Mitochondria-targeting ceria nanoparticles as antioxidants for alzheimer’s disease. ACS Nano, 2016, 10: 2860–2870
Lin F, Bao YW, Wu FG. Improving the phototherapeutic efficiencies of molecular and nanoscale materials by targeting mitochondria. Molecules, 2018, 23: 3016
Zhou L, Wu Y, Meng X, et al. Dye-anchored MnO nanoparticles targeting tumor and inducing enhanced phototherapy effect via mitochondria-mediated pathway. Small, 2018, 14: 1801008
Wang XH, Peng HS, Yang W, et al. Mitochondria-targeted ther-anostic nanoparticles for optical sensing of oxygen, photodynamic cancer therapy, and assessment of therapeutic efficacy. Microchim Acta, 2016, 183: 2723–2731
Tu Z, Qiao H, Yan Y, et al. Directed graphene-based nanoplat-forms for hyperthermia: overcoming multiple drug resistance. Angew Chem Int Ed, 2018, 57: 11198–11202
Sibrian-Vazquez M, Nesterova IV, Jensen TJ, et al. Mitochondria targeting by guanidine- and biguanidine-porphyrin photo-sensitizers. Bioconjugate Chem, 2008, 19: 705–713
Han K, Lei Q, Wang SB, et al. Dual-stage-light-guided tumor inhibition by mitochondria-targeted photodynamic therapy. Adv Funct Mater, 2015, 25: 2961–2971
Ju E, Li Z, Liu Z, et al. Near-infrared light-triggered drug-delivery vehicle for mitochondria-targeted chemo-photothermal therapy. ACS Appl Mater Interfaces, 2014, 6: 4364–4370
Zhou F, Wu S, Wu B, et al. Mitochondria-targeting single-walled carbon nanotubes for cancer photothermal therapy. Small, 2011, 7: 2727–2735
Liang C, Xu L, Song G, et al. Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy. Chem Soc Rev, 2016, 45: 6250–6269
Mou J, Chen Y, Ma M, et al. Facile synthesis of liposome/Cu2-xS-based nanocomposite for multimodal imaging and photothermal therapy. Sci China Mater, 2015, 58: 294–301
Xing R, Liu K, Jiao T, et al. An injectable self-assembling collagen-gold hybrid hydrogel for combinatorial antitumor photothermal/ photodynamic therapy. Adv Mater, 2016, 28: 3669–3676
Lu X, Li Y, Bai X, et al. Multifunctional Cu1.94S-Bi2S3@polymer nanocomposites for computed tomography imaging guided photothermal ablation. Sci China Mater, 2017, 60: 777–788
Gao G, Jiang YW, Jia HR, et al. From perinuclear to intranuclear localization: a cell-penetrating peptide modification strategy to modulate cancer cell migration under mild laser irradiation and improve photothermal therapeutic performance. Biomaterials, 2019, 223: 119443
Abadeer NS, Murphy CJ. Recent progress in cancer thermal therapy using gold nanoparticles. J Phys Chem C, 2016, 120: 4691–4716
Liu Z, Cai W, He L, et al. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotech, 2007, 2: 47–52
Sun W, Zhang X, Jia HR, et al. Water-dispersible candle soot-derived carbon nano-onion clusters for imaging-guided photothermal cancer therapy. Small, 2019, 15: 1804575
Kim JW, Galanzha EI, Shashkov EV, et al. Golden carbon nanotubes as multimodal photoacoustic and photothermal high-contrast molecular agents. Nat Nanotech, 2009, 4: 688–694
Jiang BP, Zhou B, Lin Z, et al. Recent advances in carbon nano-materials for cancer phototherapy. Chem Eur J, 2019, 25: 3993–4004
Zhou Z, Yan Y, Wang L, et al. Melanin-like nanoparticles decorated with an autophagy-inducing peptide for efficient targeted photothermal therapy. Biomaterials, 2019, 203: 63–72
Mrówczyński R. Polydopamine-based multifunctional (nano)materials for cancer therapy. ACS Appl Mater Interfaces, 2018, 10: 7541–7561
Zhang X, Xia LY, Chen X, et al. Hydrogel-based phototherapy for fighting cancer and bacterial infection. Sci China Mater, 2017, 60: 487–503
Chen H, Zhang J, Chang K, et al. Highly absorbing multispectral near-infrared polymer nanoparticles from one conjugated backbone for photoacoustic imaging and photothermal therapy. Biomaterials, 2017, 144: 42–52
Pierini F, Nakielski P, Urbanek O, et al. Polymer-based nanomaterials for photothermal therapy: from light-responsive to multifunctional nanoplatforms for synergistically combined technologies. Biomacromolecules, 2018, 19: 4147–4167
Shao J, Ruan C, Xie H, et al. Black-phosphorus-incorporated hydrogel as a sprayable and biodegradable photothermal platform for postsurgical treatment of cancer. Adv Sci, 2018, 5: 1700848
Chen W, Ouyang J, Liu H, et al. Black phosphorus nanosheet-based drug delivery system for synergistic photodynamic/photo-thermal/chemotherapy of cancer. Adv Mater, 2017, 29: 1603864
Wu MX, Yang YW. Metal-organic framework (MOF)-based drug/cargo delivery and cancer therapy. Adv Mater, 2017, 29: 1606134
Liu Y, Zhang Y, Li X, et al. Fluorescence-enhanced covalent organic framework nanosystem for tumor imaging and photothermal therapy. Nanoscale, 2019, 11: 10429–10438
Jung HS, Verwilst P, Sharma A, et al. Organic molecule-based photothermal agents: an expanding photothermal therapy universe. Chem Soc Rev, 2018, 47: 2280–2297
Yoon HJ, Lee HS, Lim JY, et al. Liposomal indocyanine green for enhanced photothermal therapy. ACS Appl Mater Interfaces, 2017, 9: 5683–5691
Chen J, Li X, Liu X, et al. Hybrid MoSe2-indocyanine green na-nosheets as a highly efficient phototheranostic agent for photoacoustic imaging guided photothermal cancer therapy. Biomater Sci, 2018, 6: 1503–1516
Zhu YX, Jia HR, Gao G, et al. Mitochondria-acting nanomicelles for destruction of cancer cells via excessive mitophagy/autophagy-driven lethal energy depletion and phototherapy. Biomaterials, 2020, 232: 119668
Chen Z, Zhao P, Luo Z, et al. Cancer cell membrane-biomimetic nanoparticles for homologous-targeting dual-modal imaging and photothermal therapy. ACS Nano, 2016, 10: 10049–10057
Zheng M, Yue C, Ma Y, et al. Single-step assembly of DOX/ICG loaded lipid-polymer nanoparticles for highly effective chemo-photothermal combination therapy. ACS Nano, 2013, 7: 2056–2067
Jia HR, Zhu YX, Liu X, et al. Construction of dually responsive nanotransformers with nanosphere-nanofiber-nanosphere transition for overcoming the size paradox of anticancer nanodrugs. ACS Nano, 2019, 13: 11781–11792
Cheng L, He W, Gong H, et al. PEGylated micelle nanoparticles encapsulating a non-fluorescent near-infrared organic dye as a safe and highly-effective photothermal agent for in vivo cancer therapy. Adv Funct Mater, 2013, 23: 5893–5902
Yue C, Liu P, Zheng M, et al. IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy. Biomaterials, 2013, 34: 6853–6861
Luo S, Tan X, Fang S, et al. Mitochondria-targeted small-molecule fluorophores for dual modal cancer phototherapy. Adv Funct Mater, 2016, 26: 2826–2835
Zhang J, Liu Z, Lian P, et al. Selective imaging and cancer cell death via pH switchable near-infrared fluorescence and photothermal effects. Chem Sci, 2016, 7: 5995–6005
Camerin M, Rello-Varona S, Villanueva A, et al. Metallo-naphthalocyanines as photothermal sensitisers for experimental tumours: in vitro and in vivo studies. Lasers Surg Med, 2009, 41: 665–673
Mathew S, Murakami T, Nakatsuji H, et al. Exclusive photothermal heat generation by a gadolinium bis(naphthalocyanine) complex and inclusion into modified high-density lipoprotein nanocarriers for therapeutic applications. ACS Nano, 2013, 7: 8908–8916
Lim CK, Shin J, Lee YD, et al. Phthalocyanine-aggregated polymeric nanoparticles as tumor-homing near-infrared absorbers for photothermal therapy of cancer. Theranostics, 2012, 2: 871–879
Wei JP, Chen XL, Wang XY, et al. Polyethylene glycol phospholipids encapsulated silicon 2,3-naphthalocyanine dihydroxide nanoparticles (SiNcOH-DSPE-PEG(NH2) NPs) for single NIR laser induced cancer combination therapy. Chin Chem Lett, 2017, 28: 1290–1299
Jung HS, Lee JH, Kim K, et al. A mitochondria-targeted crypto-cyanine-based photothermogenic photosensitizer. J Am Chem Soc, 2017, 139: 9972–9978
Zhou B, Li Y, Niu G, et al. Near-infrared organic dye-based nanoagent for the photothermal therapy of cancer. ACS Appl Mater Interfaces, 2016, 8: 29899–29905
Pan GY, Jia HR, Zhu YX, et al. Dual channel activatable cyanine dye for mitochondrial imaging and mitochondria-targeted cancer theranostics. ACS Biomater Sci Eng, 2017, 3: 3596–3606
Pan GY, Jia HR, Zhu YX, et al. Cyanine-containing polymeric nanoparticles with imaging/therapy-switchable capability for mitochondria-targeted cancer theranostics. ACS Appl Nano Mater, 2018, 1: 2885–2897
Jung HS, Han J, Lee JH, et al. Enhanced NIR radiation-triggered hyperthermia by mitochondrial targeting. J Am Chem Soc, 2015, 137: 3017–3023
Samali A, Robertson JD, Peterson E, et al. Hsp27 protects mitochondria of thermotolerant cells against apoptotic stimuli. Cell Stress Chaper, 2001, 6: 49–58
Gao P, Pan W, Li N, et al. Boosting cancer therapy with organelle-targeted nanomaterials. ACS Appl Mater Interfaces, 2019, 11: 26529–26558
Kim K, Choi H, Choi ES, et al. Hyaluronic acid-coated nanome-dicine for targeted cancer therapy. Pharmaceutics, 2019, 11: 301
Lapcik Jr L, Lapcik L, De Smedt S, et al. Hyaluronan: preparation, structure, properties, and applications. Chem Rev, 1998, 30: 2663–2684
Choi KY, Chung H, Min KH, et al. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials, 2010, 31: 106–114
Song E, Han W, Li C, et al. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery. ACS Appl Mater Interfaces, 2014, 6: 11882–11890
Zhang L, Gao S, Zhang F, et al. Activatable hyaluronic acid nanoparticle as a theranostic agent for optical/photoacoustic image-guided photothermal therapy. ACS Nano, 2014, 8: 12250–12258
Gao S, Wang J, Tian R, et al. Construction and evaluation of a targeted hyaluronic acid nanoparticle/photosensitizer complex for cancer photodynamic therapy. ACS Appl Mater Interfaces, 2017, 9: 32509–32519
Hyung W, Ko H, Park J, et al. Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment. Biotechnol Bioeng, 2008, 99: 442–454
Lim EK, Kim HO, Jang E, et al. Hyaluronan-modified magnetic nanoclusters for detection of CD44-overexpressing breast cancer by MR imaging. Biomaterials, 2011, 32: 7941–7950
Choi KY, Min KH, Yoon HY, et al. PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo. Biomaterials, 2011, 32: 1880–1889
Jia HR, Zhu YX, Xu KF, et al. Plasma membrane-anchorable photosensitizing nanomicelles for lipid raft-responsive and light-controllable intracellular drug delivery. J Control Release, 2018, 286: 103–113
Jia HR, Zhu YX, Xu KF, et al. Efficient cell surface labelling of live zebrafish embryos: wash-free fluorescence imaging for cellular dynamics tracking and nanotoxicity evaluation. Chem Sci, 2019, 10: 4062–4068
Wei X, Senanayake TH, Warren G, et al. Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors. Bioconjugate Chem, 2013, 24: 658–668
Seo YJ, Jeong HS, Bang EK, et al. Cholesterol-linked fluorescent molecular beacons with enhanced cell permeability. Bioconjugate Chem, 2006, 17: 1151–1155
Whitehouse WL, Noble JE, Ryadnov MG, et al. Cholesterol anchors enable efficient binding and intracellular uptake of DNA nanostructures. Bioconjugate Chem, 2019, 30: 1836–1844
Pan GY, Jia HR, Zhu YX, et al. Turning double hydrophilic into amphiphilic: IR825-conjugated polymeric nanomicelles for near-infrared fluorescence imaging-guided photothermal cancer therapy. Nanoscale, 2018, 10: 2115–2127
Gao G, Jiang YW, Sun W, et al. Molecular targeting-mediated mild-temperature photothermal therapy with a smart albumin-based nanodrug. Small, 2019, 15: 1900501
Garcia-Carbonero R, Supko JG. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins. Clin Cancer Res, 2002, 8: 641–661
Yang L, Cui F, Cun D, et al. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles. Int J Pharm, 2007, 340: 163–172
Sanchez-Alcazar JA, Ault JG, Khodjakov A, et al. Increased mitochondrial cytochrome c levels and mitochondrial hyperpolar-ization precede camptothecin-induced apoptosis in jurkat cells. Cell Death Differ, 2000, 7: 1090–1100
Fulda S. Apoptosis pathways and neuroblastoma therapy. Curr Pharm Design, 2009, 15: 430–435
Vakifahmetoglu-Norberg H, Ouchida AT, Norberg E. The role of mitochondria in metabolism and cell death. Biochem BioPhys Res Commun, 2017, 482: 426–431
Bank A, Wang P, Du C, et al. SMAC mimetics sensitize nonsteroidal anti-inflammatory drug induced apoptosis by promoting caspase-3 mediated cytochrome c release. Cancer Res, 2008, 68: 276–284
Ow YLP, Green DR, Hao Z, et al. Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol, 2008, 9: 532–542
Porter AG, Tanicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ, 1999, 6: 99–104
Tang W, Zhang Y, Qian C, et al. Induction and mechanism of apoptosis by hydroxycamptothecin in human tenon’s capsule fibroblasts. Invest Ophthalmol Vis Sci, 2012, 53: 4874–4880
Acknowledgements
This work was supported by the National Natural Science Foundation of China (21673037).
Author information
Authors and Affiliations
Contributions
Author contributions Liu X, Zhu Y, Xu K, and Yu X performed the experiments. Liu X, Jia H, Gao G, Jiang Y, and Wu F analyzed the data. Liu X, Jia H, Zhu Y, Cheng X, and Wu F wrote the manuscript. Wu F supervised the project.
Corresponding author
Ethics declarations
Conflict of interest The authors declare that they have no conflict of interest.
Additional information
Fu-Gen Wu is a professor of biomedical engineering at Southeast University, Nanjing, China. He obtained his BSc and PhD degrees from Tsinghua University in 2006 and 2011, respectively. After a postdoctoral period at the University of Michigan-Ann Arbor, he joined Southeast University in 2013 and was promoted to be a professor. His main research interests are biomaterials, nanomedicine, and cell imaging.
Xiaoyang Liu received his BSc degree from Northeastern University in 2017. In 2015, he became a visiting student at Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, and carried out research on photo-acoustic imaging. He is currently a postgraduate student at Southeast University under the supervision of Prof. Fu-Gen Wu and Prof. Zhan Chen. His current research is focused on the nanomedicine for cancer therapy.
Supplementary Information
Rights and permissions
About this article
Cite this article
Liu, X., Jia, HR., Zhu, YX. et al. Mitochondrion- and nucleus-acting polymeric nanoagents for chemo-photothermal combination therapy. Sci. China Mater. 63, 851–863 (2020). https://doi.org/10.1007/s40843-019-1260-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40843-019-1260-y